Global HEOR & Value Director - Payer Strategy & Launch

Jazz Pharmaceuticals, Inc.; Greater London; On-site; GBP 157,000 - 236,000; Full time

Benefits offered by this job

Medical, dental, and vision insurance

401(k) retirement plan

Flexible paid vacation

Job summary

Jazz Pharmaceuticals, Inc. seeks a Director of Global Value and HEOR to define and drive payer evidence strategy for pipeline assets from early development through launch.

You will lead global payer evidence generation and US HEOR deliverables, coordinating with Clinical Development, Market Access, and Regulatory teams to embed HTA readiness within trial designs and evidence development programs. The role focuses on innovative modeling, real-world data, and payer communications, including

Qualifications

• Expertise in health economic modeling (Markov, microsimulation, BIM, CEA).
• Experience influencing Phase 2/3 trial design and HTA readiness.
• Strong collaboration with clinical development, market access, and regulatory teams.

Responsibilities

• Lead Global and US pre-launch HEOR strategy and execution.
• Develop and validate global core economic models for dual EU/INT and US use.
• Author and oversee US AMCP PIE dossiers, burden-of-illness workups, and budget impact analyses.
• Mentor junior HEOR staff and guide cross-functional HEOR initiatives.
• Partner with EU/INT HEOR teams to adapt HTA evidence for multiple markets.
• Drive launch readiness workstreams and ensure Day 1 access deliverables.

Skills

HEOR leadership

Health economic modeling

Trial design collaboration

Strategic communication

Education

Master’s degree in Health Economics / Outcomes Research

Job description

Jazz Pharmaceuticals, Inc. seeks a Director of Global Value and HEOR to define and drive payer evidence strategy for pipeline assets from early development through launch.

You will lead global payer evidence generation and US HEOR deliverables, coordinating with Clinical Development, Market Access, and Regulatory teams to embed HTA readiness within trial designs and evidence development programs. The role focuses on innovative modeling, real-world data, and payer communications, including